HIGHLIGHTS
- who: Mats Van Delen and colleagues from the Laboratory of Experimental Hematology, Vaccine and Infectious Disease Institute (VAXINFECTIO), Faculty of Medicine and Health Sciences, University of Antwerp, Antwerp, Belgium have published the Article: Tolerogenic Dendritic Cells Induce Apoptosis-Independent T Cell Hyporesponsiveness of SARS-CoV-2-Specific T Cells in an Antigen-Specific Manner, in the Journal: (JOURNAL) of 11/03/2020
- what: The authors aimed to counteract this high inflammatory state by inducing T-cell hyporesponsiveness in a using tolerogenic dendritic cells (tolDC). The authors demonstrate a significant decrease in the number of interferon . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.